Takahashi Shin 高橋信

… Alternative Names

TAKAHASHI Shin 高橋信

Less

Researcher Number	20431570
Other IDs
Affiliation (based on the past Project Information) *help	2022: 東北大学, 医学系研究科, 非常勤講師 2019 – 2021: 東北大学, 大学病院, 講師 2017: 東北大学, 大学病院, 講師 2015 – 2016: 東北大学, 加齢医学研究所, 助教 2013: 東北大学, 加齢医学研究所, 助教 2012: 東北大学, 大学病院, 助教 2008 – 2011: 東北大学, 病院, 助教
Review Section/Research Field	Principal Investigator Tumor diagnosis / Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor diagnostics Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics / Laboratory medicine
Keywords	Principal Investigator 遺伝子発現プロファイル / バイオマーカー / 治療効果予測 / 予後予測 / TP53 / 予後因子 / TP53 signature / 乳がん Except Principal Investigator 大腸癌 / DNAメチル化 … More / 薬剤耐性 / 抗EGFR抗体薬 / 高DNAメチル化型大腸癌 / 診断と治療 / 分子機構 / 免疫学的微小環境 / シグナル伝達異常 / 薬剤抵抗性克服 / DNA高メチル化型大腸癌 / miR-193a-3p / 薬剤感受性 / BRAF変異型大腸癌 / エピジェネティクス / 分子標的治療薬 / バイオマーカー / 抗がん薬 / 感受性予測 / 再発予測 / 分子マーカー / 予後予測 / 抗がん剤感受性予測 / 腫瘍検査学 Less

Research to apply the TP53 signature to cancer types other than breast cancerPrincipal Investigator
- Principal Investigator
  
  Takahashi Shin
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Tohoku University
Research on pathogenesis of DNA-highly methylated type colorectal cancer and the development of diagnosis and treatment methods
- Principal Investigator
  
  ISHIOKA Chikashi
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Tohoku University
Development of TP53 signature in vitro diagnostics (IVD)Principal Investigator
- Principal Investigator
  
  Takahashi Shin
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor diagnostics
- Research Institution
  Tohoku University
Study on anti-EGFR antibody-resistant conquest of high DNA methylation type colorectal cancer
- Principal Investigator
  
  Ishioka Chikashi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Tohoku University
Development of biomarker of Breast cancer and retrospective analysis to confirm clinical efficacy of the biomarkerPrincipal Investigator
- Principal Investigator
  
  TAKAHASHI Shin
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor diagnosis
- Research Institution
  Tohoku University
Development of diagnostic system to predict chemosensitivity and prognosis of colorectal cancerPrincipal Investigator
- Principal Investigator
  
  TAKAHASHI Shin
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor diagnosis
- Research Institution
  Tohoku University
Screening molecular markers for prediction of recurrence and prognosis of colorectal cancer.
- Principal Investigator
  
  ISHIOKA Chikashi
- Project Period (FY)
  2008 – 2010
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Laboratory medicine
- Research Institution
  Tohoku University

[Journal Article] Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types2023
- Author(s)
  Sasaki Keiju、Takahashi Shin、Ouchi Kota、Otsuki Yasufumi、Wakayama Shonosuke、Ishioka Chikashi
- Journal Title
  
  Scientific Reports
  
  Volume: 13 Issue: 1
- DOI
  10.1038/s41598-023-32092-8
- Data Source
  KAKENHI-PROJECT-20K07692
[Journal Article] TP53 signature can predict pathological response from neoadjuvant chemotherapy and is a prognostic factor in patients with residual disease2023
- Author(s)
  Shin Takahashi, Keiju Sasaki, Chikashi Ishioka
- Journal Title
  
  Breast Cancer: Basic and Clinical Research
  
  Volume: -
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07692
[Journal Article] A modified MethyLight assay predicts the clinical outcomes of anti-epidermal growth factor receptor treatment in metastatic colorectal cancer2022
- Author(s)
  Ouchi K, Takahashi S, Okita A, Sakamoto Y, Muto O, Amagai K, Okada T, Ohori H, Shinozaki E, Ishioka C.
- Journal Title
  
  Cancer Science
  
  Volume: 113 Issue: 3 Pages: 1057-1068
- DOI
  10.1111/cas.15252
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03508
[Journal Article] TP53 signature diagnostic system using multiplex reverse transcription-polymerase chain reaction system enables prediction of prognosis of breast cancer patients2021
- Author(s)
  Takahashi S, Fukui T, Nomizu T, Kakugawa Y, Fujishima F, Ishida T, Ohuchi N, Ishioka C.
- Journal Title
  
  Breast Cancer
  
  Volume: 28(6) Issue: 6 Pages: 1225-1234
- DOI
  10.1007/s12282-021-01250-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K07692
[Journal Article] Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer.2021
- Author(s)
  Takahashi S，Sakamoto Y，Denda T，Takashima A，Komatsu Y，Nakamura M，Ohori H，Yamaguchi T，Kobayashi Y，Baba H，Kotake M，Amagai K，Kondo H，Shimada K，Sato A，Yuki S，Okita A，Ouchi K，Komine K，Watanabe M，Morita S，Ishioka C.
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 4 Pages: 1567-1578
- DOI
  10.1111/cas.14841
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19H03508
[Journal Article] Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer2021
- Author(s)
  Hiraide S, Takahashi M, Yoshida Y, Yamada H, Komine K, Ishioka C.
- Journal Title
  
  Cancer Science
  
  Volume: 112 Issue: 9 Pages: 3856-3870
- DOI
  10.1111/cas.15075
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03508, KAKENHI-PROJECT-21K07169
[Journal Article] Consensus molecular subtypes classification of colorectal cancer2018
- Author(s)
  Okita, A.，Takahashi, S.，Ouchi, K.，Inoue, M.，Yamada, Y.，Ishioka, C.
- Journal Title
  
  Oncotarget
  
  Volume: 9 Issue: 4 Pages: 18698-18711
- DOI
  10.1007/s10147-018-1261-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H04307, KAKENHI-PROJECT-16K07106
[Journal Article] Molecular and clinical features of the TP53 signature gene expression profile in early-stage breast cancer.2018
- Author(s)
  Yamaguchi S, Takahashi S, Mogushi K, Izumi Y, Nozaki Y, Nomizu T, Kakugawa Y, Ishida T, Ohuchi N, Ishioka C, Kato S.
- Journal Title
  
  Oncotarget
  
  Volume: 9(18) Issue: 18 Pages: 14193-14206
- DOI
  10.18632/oncotarget.24447
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K10035, KAKENHI-PROJECT-17K10652, KAKENHI-PROJECT-15K06851, KAKENHI-PROJECT-15K10081, KAKENHI-PROJECT-16K11029
[Journal Article] microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer.2017
- Author(s)
  Takahashi, H.，Takahashi, M.，Ohnuma, S.，Unno, M.，Yoshino, Y.，Ouchi, K.，Takahashi, S.，Yamada, Y.，Shimodaira, H.，Ishioka, C.:
- Journal Title
  
  BMC Cancer
  
  Volume: 17 Issue: 1 Pages: 723-727
- DOI
  10.1186/s12885-017-3739-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15H04307, KAKENHI-PROJECT-15K08962, KAKENHI-PROJECT-15K10128
[Journal Article] CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer.2016
- Author(s)
  Zhang, X.，Shimodaira, H.，Soeda, H.，Komine, K.，Takahashi, H.，Ouchi, K.，Inoue, M.，Takahashi, M.，Takahashi, S.，Ishioka, C.
- Journal Title
  
  Int J Clin Oncol
  
  Volume: 21 Issue: 6 Pages: 1091-1101
- DOI
  10.1007/s10147-016-1017-6
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15H04307, KAKENHI-PROJECT-26460958
[Journal Article] DNA methylation status as a biomarker of anti-epidermal growth factor receptor treatment for metastatic colorectal cancer.2015
- Author(s)
  Ouchi K, Takahashi S, Yamada Y, Tsuji S, Tatsuno K, Takahashi H, Takahashi N, Takahashi M, Shimodaira H, Aburatani H, Ishioka C.
- Journal Title
  
  Cancer Science
  
  Volume: 106 Issue: 12 Pages: 1722-1729
- DOI
  10.1111/cas.12827
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08962, KAKENHI-PROJECT-26460958, KAKENHI-PROJECT-24221011, KAKENHI-PROJECT-15H04307
[Journal Article] Contribution of autophagic cell death to p53-dependent cell death in human glioblastoma cell line SF1262011
- Author(s)
  Sakamoto Y, Kato S, Takahashi M, Okada Y, Yasuda K, Watanabe G, Imai H, Sato A, Ishioka C
- Journal Title
  
  Cancer Sci
  
  Volume: 102 Pages: 799-807
- NAID
  10029292419
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20390163
[Journal Article] Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer2009
- Author(s)
  Yoshioka T, Kato S, Gamoh M, Chiba N, Suzuki T, Sakayori N, Kato S, Shibata H, Shimodaira H, Otsuka K, Kakudo Y, Takahashi S, Ishioka C
- Journal Title
  
  Br J Cancer
  
  Volume: 101 Pages: 1972-7
- Data Source
  KAKENHI-PROJECT-20390163
[Journal Article] Newly synthesized cur cumin analog has improved potential to prevent colorectal carcinogenesis in vivo2009
- Author(s)
  Shibata, H., Yamakoshi, H., Sato, A., Ohori, H., Kakudo, Y., Kudo, C., Takahashi, Y., Watanabe, M. , Takano, H. , Ishioka, C. , Noda, T. , Iwabuchi, Y
- Journal Title
  
  Cancer Sci
  
  Volume: 100 Pages: 956-60
- NAID
  10025146044
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20390163
[Journal Article] Prediction of breast cancer prognosis by gene expression profile of TP53 status2008
- Author(s)
  Takahashi, S., Moriya, T., Ishida, T., Shibata, H., Sasano, H., Ohuchi, N., Ishioka, C
- Journal Title
  
  Cancer Sci
  
  Volume: 99 Pages: 324-32
- NAID
  10024002457
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20390163
[Patent] 遺伝子発現解析による大腸がんの病型分類に基づく抗癌剤応答性及び予後の予測方法2012
- Inventor(s)
  石岡千加史、高橋信、井上正広
- Industrial Property Rights Holder
  国立大学法人東北大学
- Filing Date
  2012-03-10
- Data Source
  KAKENHI-PROJECT-22700902
[Patent] 遺伝子発現解析による大腸がんの病型分類に基づく抗癌剤応答性及び予後の予測方法2012
- Inventor(s)
  石岡千加史, 高橋信, 井上正広
- Industrial Property Rights Holder
  国立大学法人東北大学
- Industrial Property Number
  2012-053883
- Filing Date
  2012-03-10
- Data Source
  KAKENHI-PROJECT-22700902
[Patent] がんの予後予測方法2009
- Inventor(s)
  石岡千加史、高橋信
- Industrial Property Rights Holder
  東北大学
- Acquisition Date
  2009-09-11
- Data Source
  KAKENHI-PROJECT-20390163
[Presentation] TP53 signatureによる乳がんの治療効果および予後予測性に関する検証試験2021
- Author(s)
  高橋信、佐藤信昭、金子耕司、増田慎三、岩田広治、服部正也、坂東裕子、山内英子、藤島史喜、齋藤辰朗、袁媛、高橋史朗、山口拓洋、石岡千加史
- Organizer
  第29回日本乳癌学会学術総会
- Data Source
  KAKENHI-PROJECT-20K07692
[Presentation] The functional roles of miRNA-193a-3p in colorectal cancer.2021
- Author(s)
  Hiraide S, Takahashi M, Yoshida Y, Komine K, Ishioka C.
- Organizer
  AACR Annual Meeting 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19H03508
[Presentation] 高メチル化大腸がんが抗EGFR抗体薬抵抗性となる分子生物学的メカニズムの探索2020
- Author(s)
  大内康太，高橋信，沖田啓，大槻泰史，石岡千加史
- Organizer
  第24回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-19H03508
[Presentation] Analysis of consensus molecular subtypes (CMS) classification in the TRICOLORE trial: A randomized phase 3 trial of S-1 and irinotecan plus bevacizumab versus mFOLFOX6 or CapeOX plus bevacizumab as first-line treatment for metastatic colorectal cancer．2020
- Author(s)
  1.Yuki S，Gamoh M，Denda T，Takashima A，Takahashi S，Nakamura M，Ohori H，Yamaguchi T，Kobayashi Y，Baba H，Kotake M，Amagi K，Kondo H，Shimada K，Sato A，Ishioka C，Komine K，Ouchi K，Morita S，Komatu Y
- Organizer
  ASCO 2020 Gastrointestinal Cancers Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19H03508
[Presentation] Development of an in vitro diagnostic test to predict the clinical outcome of anti-EGFR treatment based on DNA methylation status.2020
- Author(s)
  Ouchi K，Takahashi S，Ishioka C
- Organizer
  7th US-Japan Workshop on Biomarkers for Cancer Early Detection.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19H03508
[Presentation] Development of novel in vitro diagnostics to predict the efficacy of anti-EGFR treatment based on DNA methylation status．2019
- Author(s)
  4.大内康太，高橋信，沖田啓，坂本康寛，武藤理，天貝賢二，岡田恭穂，大堀久詔，篠崎英司，蒲生真紀夫，石岡千加史
- Organizer
  第 17 回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-19H03508
[Presentation] The consensus molecular subtypes of colorectal cancer as a predictive factor for chemotherapies against metastatic colorectal cancer．2018
- Author(s)
  Okita, A.，Takahashi, S.，Ouchi, K.，Inoue, M.，Yamada, Y.，Ishioka, C
- Organizer
  2018 Gastrointestinal Cancers Symposium，
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04307
[Presentation] Development of TP53 signature diagnostic system using multiplex RT-PCR and observational study to confirm the prognostic value of TP53 signature in breast cancer2017
- Author(s)
  Shin Takahashi, Takafumi Fukui, Tadashi Nomizu, Yoichiro Kakugawa, Takanori Ishida, Shigeo Yamguchi, Shunsuke Kato, Noriaki Ouchi, Nobuhisa Gondo, Chikashi Ishioka
- Organizer
  European Society of Medical Oncology (ESMO) 2017 Congress, Madrid, Spain
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K06851
[Presentation] Consensus molecular subtypes（CMS）に基づく、進行・再発大腸癌に対する最適な化学療法の検討2017
- Author(s)
  沖田啓，高橋信，大内康太，山田英晴，笠原佑記，近松園子，高橋秀和，高橋雅信，下平秀樹，石岡千加史
- Organizer
  第15回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-15H04307
[Presentation] Molecular and clinical features of the TP53 signature gene expression profile in early-stage breast cancer2017
- Author(s)
  Yamaguchi Shigeo、Takahashi Shin、Mogushi Kaoru、Izumi Yuki、Nozaki Yumi、Nomizu Tadashi、Kakugawa Yoichiro、Ishida Takanori、Ohuchi Noriaki、Ishioka Chikashi、Kato Shunsuke
- Organizer
  European Society of Medical Oncology (ESMO) 2017 Congress, Madrid, Spain
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K06851
[Presentation] 大腸がんに対する抗EGFR抗体薬の効果を予測する新規バイオマーカー・DNAメチル化状態診断キットの開発．2017
- Author(s)
  石岡千加史，高橋信，大内康太，高橋雅信，永江玄太
- Organizer
  ジャパン・キャンサーリサーチ・プロジェクト　平成28年度企業向け成果発表会
- Place of Presentation
  アキバホール（東京都・秋葉原）
- Invited
- Data Source
  KAKENHI-PROJECT-15H04307
[Presentation] 進行大腸癌の新しい分子標的薬とバイオマーカーの開発．2017
- Author(s)
  石岡千加史，西條憲，高橋信，大内康太，今井源，高橋雅信
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-15H04307
[Presentation] Development of in vitro diagnostics for TP53 signature aiming at optimization of breast cancer treatment2017
- Author(s)
  Shin Takahashi, Takafumi Fukui, Tadashi Nomizu, Yoichiro Kakugawa, Takanori Ishida, Shigeo Yamguchi, Shunsuke Kato, Noriaki Ouchi, Nobuhisa Gondo, Chikashi Ishioka
- Organizer
  第15回日本臨床腫瘍学会学術集会神戸国際会議場（兵庫）
- Data Source
  KAKENHI-PROJECT-15K06851
[Presentation] TP53 signatureによる乳がんの予後および治療効果予測2017
- Author(s)
  高橋信
- Organizer
  20th BREAST CANCER UP-TO-DATE Meeting
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-15K06851
[Presentation] microRAN-193a-3p acts as a tumor suppressor in BRAF-mutated colorectal cancer．2016
- Author(s)
  Takahashi, H.，Takahashi, M.，Takahashi, S.，H., S.，Ishioka, C.
- Organizer
  AACR 2016
- Place of Presentation
  New Orleans, USA
- Year and Date
  2016-04-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04307
[Presentation] Development of in vitro diagnostics for TP53 signature aiming at optimization of breast cancer treatment2016
- Author(s)
  高橋信、福井崇史、野水整、角川陽一郎、山口茂夫、加藤俊介、石岡千加史
- Organizer
  第14回日本臨床腫瘍学会学術集会
- Place of Presentation
  神戸
- Year and Date
  2016-07-28
- Data Source
  KAKENHI-PROJECT-15K06851
[Presentation] TP53ステータスを利用した乳がんの予後予測バイオマーカーの開発2014
- Author(s)
  高橋信, 福井崇史, 権藤延久, 石岡千加史
- Organizer
  第111回日本内科学会総会・講演会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-24701000
[Presentation] TP53-mutation status by gene expression signature (TP53 signature) predicts efficacy of neoadjuvant chemotherapy (NAC) and recurrence after surgery in breast cancer2014
- Author(s)
  Shin Takahashi, Takafumi Fukui, Nobuhisa Gondo, Takanori Ishida, Noriaki Ohuchi, Tadashi Nomizu, Youichiro Kakugawa, Chikashi Ishioka
- Organizer
  American Society of Clinical Oncology 50^<th> annual meeting
- Place of Presentation
  Chicago, USA
- Data Source
  KAKENHI-PROJECT-24701000
[Presentation] TP53 signature predicts the efficacy of neoadjuvant chemotherapy (NAC) of breast cancer2014
- Author(s)
  Shin Takahashi, Takafumi Fukui, Nobuhisa Gondo, Takanori Ishida, Noriaki Ohuchi, Tadashi Nomizu, Youichiro Kakugawa, Chikashi Ishioka
- Organizer
  第12回日本臨床学会学術集会
- Place of Presentation
  福岡(発表確定)
- Data Source
  KAKENHI-PROJECT-24701000
[Presentation] TP53-mutation status by gene-expression signature (TP53 signature) and prediction of efficacy of neoadjuvant chemotherapy (NAC) and recurrence after surgery in breast cancer.2014
- Author(s)
  Shin Takahashi
- Organizer
  American Society of Clinical Oncology 50th annual meeting
- Place of Presentation
  アメリカ・シカゴ
- Data Source
  KAKENHI-PROJECT-24701000
[Presentation] TP53 signature predicts the efficacy of neoadjuvant chemotherapy (NAC) of breast cancers.2014
- Author(s)
  Shin Takahashi
- Organizer
  第12回日本臨床腫瘍学会学術集会
- Place of Presentation
  福岡
- Data Source
  KAKENHI-PROJECT-24701000
[Presentation] 遺伝子発現プロファイルによるTP53ステータスの臨床的有用性2013
- Author(s)
  高橋信, 福井崇史, 権藤延久, 石田孝宣, 大内憲明, 野水整, 角川陽一郎, 石岡千加史
- Organizer
  第51回日本癌治療学会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-24701000
[Presentation] 遺伝子発現プロファイルによるTP53ステータスの臨床的有用性2013
- Author(s)
  高橋　信
- Organizer
  第51回日本癌治療学会学術集会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-24701000
[Presentation] 網羅的遺伝子発現解析による大腸癌の臨床像と分子生物学的特徴の解析2012
- Author(s)
  井上正広、高橋信
- Organizer
  第109回日本内科学会
- Place of Presentation
  京都
- Year and Date
  2012-04-13
- Data Source
  KAKENHI-PROJECT-22700902
[Presentation] 網羅的遺伝子発現解析による大腸癌の臨床像と分子生物学的特徴の解析2012
- Author(s)
  井上正広、高橋信
- Organizer
  日本内科学会
- Place of Presentation
  京都
- Year and Date
  2012-04-13
- Data Source
  KAKENHI-PROJECT-22700902
[Presentation] Predictive of colorectal cancer prognosis by gene expression profile using FFPE sample2011
- Author(s)
  井上正広、高橋信
- Organizer
  第70回日本癌学会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-22700902
[Presentation] A randomized pilot study comparing safety and efficacy of irinotecan plus S-1 (IRIS)plus bevacizumab (BV)and modified (m)FOLFIRI plus BV in patients (pts)with metastatic colorectal cancer (marc): First report of T-CORE07022011
- Author(s)
  Kato, S. , Andoh, H. , Gamoh, M. , Yamaguchi, T. , Murakawa, Y. , Sasaki, Y. , Takahashi, S. , Shimodaira, H. , Yoshioka, T. , Ishioka, C.
- Organizer
  2011 Gastrointestinal Cancers Symposium
- Place of Presentation
  Florida・Orland world Center Marriott.General Poster Session C
- Year and Date
  2011-01-22
- Data Source
  KAKENHI-PROJECT-20390163
[Presentation] Predictive of colorectal cancer prognosis by gene expression profile using FFPE sample2011
- Author(s)
  井上正広、高橋信
- Organizer
  日本癌学会
- Place of Presentation
  名古屋
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-22700902
[Presentation] MSH2のintron5のsplice donor siteに変異を認めたHNPCCの一家系2009
- Author(s)
  高橋雅信
- Organizer
  第15回日本家族性腫瘍学会学術集会
- Place of Presentation
  秋葉原コンベンションホール(東京都)
- Year and Date
  2009-06-12
- Data Source
  KAKENHI-PROJECT-20390163

1. ISHIOKA Chikashi (60241577)

# of Collaborated Projects: 3 results

# of Collaborated Products: 21 results
2. TAKAHASHI Masanobu (00447161)

# of Collaborated Projects: 3 results

# of Collaborated Products: 23 results
3. 大内康太 (50781291)

# of Collaborated Projects: 2 results

# of Collaborated Products: 13 results
4. OKITA Akira

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
5. KOBAYASHI Akihiro

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. TAKAHASHI Hidekazu

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. MOGUSHI Kaoru

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 加藤俊介

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 高橋玄

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Takahashi Shin 高橋 信

TAKAHASHI Shin 高橋 信

Research Projects

Research Products

Co-Researchers

Research to apply the TP53 signature to cancer types other than breast cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Research on pathogenesis of DNA-highly methylated type colorectal cancer and the development of diagnosis and treatment methods

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of TP53 signature in vitro diagnostics (IVD)Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Study on anti-EGFR antibody-resistant conquest of high DNA methylation type colorectal cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of biomarker of Breast cancer and retrospective analysis to confirm clinical efficacy of the biomarkerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of diagnostic system to predict chemosensitivity and prognosis of colorectal cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Screening molecular markers for prediction of recurrence and prognosis of colorectal cancer.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Different impacts of TP53 mutations on cell cycle-related gene expression among cancer types2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] TP53 signature can predict pathological response from neoadjuvant chemotherapy and is a prognostic factor in patients with residual disease2023

Author(s)

Journal Title

Data Source

[Journal Article] A modified MethyLight assay predicts the clinical outcomes of anti-epidermal growth factor receptor treatment in metastatic colorectal cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] TP53 signature diagnostic system using multiplex reverse transcription-polymerase chain reaction system enables prediction of prognosis of breast cancer patients2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Consensus molecular subtypes classification of colorectal cancer2018

Author(s)

Journal Title

DOI

Takahashi Shin 高橋信

TAKAHASHI Shin 高橋信